Pfizer-Funded Study Shows Poor Effectiveness For COVID Vaccine In Young Children
Three doses of the Pfizer vaccine provided little protection against emergency room visits, urgent care encounters, or outpatient visits.
View Source | September 21, 2023 3:25 pm
- A new study funded by Pfizer found the company’s COVID-19 vaccine did not perform well in children under 5.
- Children aged 6 months to 4 years are supposed to receive three shots of the Pfizer-BioNTech vaccine. The number was increased from two when early testing showed little effectiveness.
- Three doses of the Pfizer vaccine provided little protection against emergency room visits, urgent care encounters, or outpatient visits, according to the new study.
Click to read full article
Go back home
Share This Article: